Longer Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-37,348
Closed -$1.14M 54
2015
Q4
$1.14M Sell
37,348
-26,927
-42% -$847K 1.01% 31
2015
Q3
$1.92M Buy
64,275
+118
+0.2% +$3.78K 2.26% 14
2015
Q2
$2.04M Sell
64,157
-20,005
-24% -$652K 1.79% 15
2015
Q1
$2.78M Sell
84,162
-290
-0.3% -$9.22K 2.12% 15
2014
Q4
$2.5M Buy
84,452
+12,084
+17% +$346K 1.85% 21
2014
Q3
$2.03M Sell
72,368
-16,331
-18% -$458K 1.64% 21
2014
Q2
$2.5M Buy
88,699
+4,542
+5% +$129K 1.89% 19
2014
Q1
$2.56M Buy
84,157
+174
+0.2% +$5.19K 2.04% 18
2013
Q4
$2.44M Buy
83,983
+15,378
+22% +$448K 1.91% 20
2013
Q3
$1.87M Sell
68,605
-158
-0.2% -$4.3K 1.5% 26
2013
Q2
$1.83M Buy
+68,763
New +$1.9M 1.66% 23

Other funds holding PFE

Longer Investments's PFE Position: Q1 2016 in Review

Longer Investments sold out of Pfizer (PFE) in Q1 2016, closing a stake of 37,348 shares — an estimated $1.14M sold.

Longer Investments first reported a position in PFE in Q2 2013 and held it in 11 quarters. The position peaked at $2.78M in Q1 2015. 1,969 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

  • Longer Investments reported no remaining Pfizer position as of Q1 2016 after selling out during the quarter.
  • Longer Investments sold 37,348 Pfizer shares in Q1 2016, an estimated $1.14M.
  • Longer Investments first reported a position in Pfizer in Q2 2013 and held it in 11 quarters.
  • Longer Investments's Pfizer position peaked at $2.78M in Q1 2015.
  • 1,969 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on Longer Investments's 13F filing for Q1 2016, filed 27 Apr 2016.